Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)
Authors
György Sinkovits (ORCID: https://orcid.org/0000-0002-5355-7318)
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)
György Sinkovits, Kazuya Sakai, Xiaopu Zheng, Michaela Larissa Lobo de Andrade et al.
Citations
25 citations
Journal
EClinicalMedicine
Topics
Complement system in diseases
Field-Weighted Citation Impact (FWCI)
19.94
article
Caplacizumab use in immune-mediated thrombotic thrombocytopenic purpura: an international multicentre retrospective Cohort study (The Capla 1000+ project)
György Sinkovits, Kazuya Sakai, Xiaopu Zheng, Michaela Larissa Lobo de Andrade, T Boechat, Raïda Bouzid, Julio del Río-Garma, Bérangère S. Joly, Ilaria Mancini, Eleni Gavriilaki, Javier de la Rubia, María Eva Mingot‐Castellano, Agnès Veyradier, Bernhard Lämmle, Paul Coppo, Michaël Bubenheim, Shruti Chaturvedi, Spero R. Cataland, Matthew Stubbs, Y. Benhamou, João Samuel de Holanda Farias, Flora Peyvandi, Masanori Matsumoto, Marshall Mazepa, Eduardo Flávio Oliveira Ribeiro, Paul Knoebl, Camila Masias, Pasquale Agosti, Lucas Kühne, Katerina Pavenski, Marienn Réti, Amjad Hmaid, Cristina Pascual, Christopher J. Patriquin, Paul Brinkkötter, Linus Völker, Marie Scully
article en
25 citations
Abstract
No abstract available for this paper.
Publication Tag
EClinicalMedicineVol. 82
Institutions
Semmelweis University (HU), University of Bern (CH), St. Michael's Hospital (CA), University of Minnesota (US), University Health Network (CA), University College London Hospitals NHS Foundation Trust (GB), Johns Hopkins University (US), Inserm (FR), University of Milan (IT), Johannes Gutenberg University Mainz (DE), University Hospital of Bern (CH), Fondazione IRCCS Ca' Granda Ospedale Maggiore Policlinico (IT), Hospital General Universitario Gregorio Marañón (ES), Hospital Universitari i Politècnic La Fe (ES), Sorbonne Université (FR), Hemorio (BR), Hôpital Charles-Nicolle (FR), Centre de Recherche des Cordeliers (FR), University Medical Center of the Johannes Gutenberg University Mainz (DE), Complejo Hospitalario Universitario de Santiago (ES), Assistance Publique – Hôpitaux de Paris (FR), Baptist Health South Florida (US), Normandie Université (FR), Hospital Erasto Gaertner (BR), Hôpital Lariboisière (FR), University of Kansas Medical Center (US), Hospital Universitário de Brasília (BR), Cologne Excellence Cluster on Cellular Stress Responses in Aging Associated Diseases (DE), Hospital Universitario Virgen del Rocío (ES), University Hospital Cologne (DE), Centre Hospitalier Universitaire de Rouen (FR), G. Papanikolaou General Hospital (GR), University College London (GB), The Ohio State University (US), Université de Rouen Normandie (FR), Nara Medical University (JP), Medical University of Vienna (AT)
Funders
Amgen, AstraZeneca, Sanofi, Alexion Pharmaceuticals, BioCryst, Deutsche Forschungsgemeinschaft, Direction Générale de l’offre de Soins, Swedish Orphan Biovitrum, Chugai Pharmaceutical, National Heart, Lung, and Blood Institute